TITLE

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review

AUTHOR(S)
Price, Hilary I.; Agnew, Meghan D.; Gamble, John-Michael
PUB. DATE
March 2015
SOURCE
BMJ Open;Mar2015, Vol. 5 Issue 3, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
101962772

 

Related Articles

  • Initiating insulin in patients with type 2 diabetes. Lau, Adrian N. C.; Tang, Terence; Halapy, Henry; Thorpe, Kevin; Yu, Catherine H. Y. // CMAJ: Canadian Medical Association Journal;4/17/2012, Vol. 184 Issue 7, p767 

    The article examines the adverse effects and barriers on initiating insulin in patients with type 2 diabetes through the result of a randomized controlled trial. The authors discuss the selection of an insulin regimen, titration, delivery of care, and how to combine insulin therapy with oral...

  • Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials. Erpeldinger, Sylvie; Rehman, Michaela B.; Berkhout, Christophe; Pigache, Christophe; Zerbib, Yves; Regnault, Francis; Guérin, Emilie; Supper, Irène; Cornu, Catherine; Kassaï, Behrouz; Gueyffier, François; Boussageon, Rémy // BMC Endocrine Disorders;7/8/2016, Vol. 16, p1 

    Background: It is essential to anticipate and limit the social, economic and sanitary cost of type 2 diabetes (T2D), which is in constant progression worldwide. When blood glucose targets are not achieved with diet and lifestyle intervention, insulin is recommended whether or not the patient is...

  • Oral sulfonylureas and CV mortality. Aronow, Wilbert S. // Geriatrics;Sep2004, Vol. 59 Issue 9, p45 

    Oral sulfonylureas, particularly the cost-effective first generation agents, are a mainstay of treatment for patients with type 2 diabetes mellitus. The University Group Diabetes Program (UGDP) found that sulfonylureas increased cardiovascular (CV) mortality in patients with diabetes mellitus....

  • Comparative efficacy and safety of insulin analogs in hospitalized adults. Singh, Kavita; Ansari, Mohammed T.; Patel, Rakesh V.; Bedard, Mario; Keely, Erin; Tierney, Mike; Moher, David // American Journal of Health-System Pharmacy;4/1/2015, Vol. 72 Issue 7, p525 

    Purpose. The comparative efficacy, safety, and cost-effectiveness of rapid and longacting insulin analogs compared with regular or neutral protamine Hagedorn nonanalog insulins or with oral antidiabetic agents in hospitalized adults were evaluated. Methods. A literature search was...

  • Adding Pioglitazone to Insulin Containing Regimens in Type 2 Diabetes: Systematic Review and Meta-Analysis. Clar, Christine; Royle, Pamela; Waugh, Norman // PLoS Clinical Trials;Jul2009, Vol. 6 Issue 7, Special section p1 

    Background: Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral antidiabetic agents and insulin. The oral agent pioglitazone is licensed for use with insulin when metformin is contraindicated or not tolerated. This systematic review and...

  • Adding Pioglitazone to Insulin Containing Regimens in Type 2 Diabetes: Systematic Review and Meta-Analysis. Clar, Christine; Royle, Pamela; Waugh, Norman // PLoS ONE;2009, Vol. 4 Issue 7, p1 

    Background: Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral antidiabetic agents and insulin. The oral agent pioglitazone is licensed for use with insulin when metformin is contraindicated or not tolerated. This systematic review and...

  • Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes. Lipscombe, Lorraine L.; Ray, K. K. // ACP Journal Club;9/22/2009, Vol. 151 Issue 3, p4 

    The article cites a study on whether glucose control reduces cardiovascular (CV) events and mortality in patients with type 2 diabetes mellitus. Studies compared intensive glucose-lowering regimens with standard regimens in patients who had significant group differences in hemoglobin Alc (HbAlc)...

  • Insulin restriction led to higher rate of mortality, complications. Blomgarden, Zachary T. // Endocrine Today;5/10/2008, Vol. 6 Issue 8, p23 

    The article presents research on the effect of insulin restriction on rates of mortality and complications in patients with diebetes, published in the 2008 issue of "Diabetes Care." The study concluded that the risk for mortality and diabetes-related complications increased in patients with...

  • Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins. Bagul, Pankaj K.; Banerjee, Sanjay K. // Current Pharmaceutical Design;Oct2013, Vol. 19 Issue 32, p5663 

    Cardiovascular disease (CVD) is one of the major lifestyle associated disorders and leading causes of death worldwide. The incidence of CVD in diabetic patients has increased up to 3 folds and it became the major risk for diabetes associated morbidity and mortality. Insulin resistance and...

  • Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins. Bagul, Pankaj K.; Banerjee, Sanjay K. // Current Pharmaceutical Design;Jun2013, Vol. 19 Issue 18-20, p5663 

    Cardiovascular disease (CVD) is one of the major lifestyle associated disorders and leading causes of death worldwide. The incidence of CVD in diabetic patients has increased up to 3 folds and it became the major risk for diabetes associated morbidity and mortality. Insulin resistance and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics